These findings establish butyrate as a dual modulator of the p62-Nrf2 antioxidant axis, highlighting its therapeutic potential for mitigating oxidative stress in K. pneumoniae-associated pneumonia. Here, SQSTM1 is linked to susceptibility to pneumonia measurement.